Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration
Yun Dong, Roman Fischer, Petrus J.W. Naudé, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 43, pp. 12304-12309
Open Access | Times Cited: 148

Showing 1-25 of 148 citing articles:

The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond
Catherine Dostert, Melanie Grusdat, Elisabeth Letellier, et al.
Physiological Reviews (2018) Vol. 99, Iss. 1, pp. 115-160
Open Access | Times Cited: 383
Post-stroke inflammation—target or tool for therapy?
Kate Lykke Lambertsen, Bente Finsen, Bettina Hjelm Clausen
Acta Neuropathologica (2018) Vol. 137, Iss. 5, pp. 693-714
Open Access | Times Cited: 369
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
Lauren Mifflin, Dimitry Ofengeim, Junying Yuan
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 8, pp. 553-571
Open Access | Times Cited: 337
Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study
Bing Zhang, Hohui E. Wang, Ya‐Mei Bai, et al.
Gut (2020) Vol. 70, Iss. 1, pp. 85-91
Closed Access | Times Cited: 236
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Ilio Vitale, Federico Pietrocola, Emma Guilbaud, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1097-1154
Open Access | Times Cited: 210
Selective Targeting of TNF Receptors as a Novel Therapeutic Approach
Roman Fischer, Roland E. Kontermann, Klaus Pfizenmaier
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 182
Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target
Juliane Medler, Harald Wajant
Expert Opinion on Therapeutic Targets (2019) Vol. 23, Iss. 4, pp. 295-307
Closed Access | Times Cited: 145
Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer’s Disease Progression
Felicia Liana Andronie-Cioară, Adriana Ioana Ardelean, Carmen Delia Nistor-Cseppento, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1869-1869
Open Access | Times Cited: 84
TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond
Daniela Siegmund, Harald Wajant
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 9, pp. 576-591
Closed Access | Times Cited: 43
Neuraxial Cytokines in Pain States
Gilson Gonçalves dos Santos, Lauriane Delay, Tony L. Yaksh, et al.
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 126
Opposing Functions of Microglial and Macrophagic TNFR2 in the Pathogenesis of Experimental Autoimmune Encephalomyelitis
Han Gao, Matt C. Danzi, Claire Choi, et al.
Cell Reports (2017) Vol. 18, Iss. 1, pp. 198-212
Open Access | Times Cited: 125
Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development
Valentina Pegoretti, Kathryn A. Swanson, John R. Bethea, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-19
Open Access | Times Cited: 119
TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice
Franziska Wandrer, Stephanie Liebig, Silke Marhenke, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 3
Open Access | Times Cited: 118
A New Venue of TNF Targeting
Sophie Steeland, Claude Libert, Roosmarijn E. Vandenbroucke
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 5, pp. 1442-1442
Open Access | Times Cited: 117
Targeting soluble tumor necrosis factor as a potential intervention to lower risk for late-onset Alzheimer’s disease associated with obesity, metabolic syndrome, and type 2 diabetes
Maria Elizabeth de Sousa Rodrigues, Madelyn C. Houser, Douglas I. Walker, et al.
Alzheimer s Research & Therapy (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 114
TNF Production and Release from Microglia via Extracellular Vesicles: Impact on Brain Functions
Stefano Raffaele, Marta Lombardi, Claudia Verderio, et al.
Cells (2020) Vol. 9, Iss. 10, pp. 2145-2145
Open Access | Times Cited: 103
Selective Modulation of TNF–TNFRs Signaling: Insights for Multiple Sclerosis Treatment
Valentina Pegoretti, Wia Baron, Jon D. Laman, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 102
Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity
Kamar‐Sulu N. Atretkhany, Ilgiz A. Mufazalov, Josefine Dunst, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 51, pp. 13051-13056
Open Access | Times Cited: 85
Insights into the biology and therapeutic implications of TNF and regulatory T cells
Benoı̂t L. Salomon
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 8, pp. 487-504
Open Access | Times Cited: 74
Importance of TNF-alpha and its alterations in the development of cancers
Pouya Mahdavi Sharif, Parnian Jabbari, Sepideh Razi, et al.
Cytokine (2020) Vol. 130, pp. 155066-155066
Closed Access | Times Cited: 73
The Link between Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation in the Pathophysiology of Alzheimer’s Disease: Therapeutic Implications and Future Perspectives
Maria Carolina Jurcău, Felicia Liana Andronie-Cioară, Anamaria Jurcău, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2167-2167
Open Access | Times Cited: 55
Neuroinflammation as a Potential Therapeutic Target in Alzheimer’s Disease
Ping Liu, Yunyun Wang, Yan Sun, et al.
Clinical Interventions in Aging (2022) Vol. Volume 17, pp. 665-674
Open Access | Times Cited: 54
Microglial Inflammatory-Metabolic Pathways and Their Potential Therapeutic Implication in Major Depressive Disorder
Reza Rahimian, Claudia Belliveau, Rebecca Chen, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 46
Reactive microglia are the major source of tumor necrosis factor alpha and contribute to astrocyte dysfunction and acute seizures in experimental temporal lobe epilepsy
Lukas Henning, Henrike Antony, Annika Breuer, et al.
Glia (2022) Vol. 71, Iss. 2, pp. 168-186
Open Access | Times Cited: 38
The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
Anamaria Jurcău, Felicia Liana Andronie-Cioară, Carmen Delia Nistor-Cseppento, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14582-14582
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top